Gregory Chua

Gregory Chua is an experienced professional in quality assurance and supply chain management, currently serving as the Associate Director of Quality Assurance at Alnylam Pharmaceuticals since August 2022. Responsibilities include oversight of GxP audits and collaboration with multiple departments to ensure compliance with quality standards. Previously, Gregory held leadership roles at EyePoint Pharmaceuticals, managing supply chain operations and vendor relationships, and at Takeda and Shire, focusing on supplier coordination and contract negotiations. With a comprehensive background at Biogen in supply chain quality and manufacturing support, combined with foundational experience in research at UMass Medical School and MatTek Corporation, Gregory possesses a strong foundation in both scientific research and operational excellence. Gregory holds a B.A. in Biology from Clark University.